Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension (Q28333637)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: September 1991)

Language	Label	Description	Also known as
English	Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension	scientific article (publication date: September 1991)

Statements

scholarly article

0 references

Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension (English)

0 references

arterial hypertension

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

M C Houston

1

0 references

L Olafsson

2

0 references

M C Burger

3

0 references

language of work or name

0 references

publication date

September 1991

0 references

0 references

42

0 references

9

0 references

681-90

0 references

Alterations in canine myocardial excitability during ischemia

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

A primary preventive study of Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Thiazides, beta blockers and lipoproteins

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Increase in serum-lipids during treatment of hypertension with chlorthalidone

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effect of chronic administration of propranolol on lipoprotein composition

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Comparison of prazosin and atenolol

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Antiatherogenic properties of calcium antagonists. State of the art.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Long-term results with verapamil in essential hypertension and its influence on serum lipids.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Perspectives on systolic hypertension. The Framingham study.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Multiple effects of calcium entry blockers on renal function in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effect of nifedipine on renal function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The relation of apolipoproteins A-I and B in children to parental myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Identifiers

10.1177/000331979104200901

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28333637&oldid=1518850006"